MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ
1.472
-0.003
-0.18%
Opening 12:36 12/19 EST
OPEN
1.430
PREV CLOSE
1.474
HIGH
1.472
LOW
1.430
VOLUME
21.24K
TURNOVER
--
52 WEEK HIGH
4.490
52 WEEK LOW
1.430
MARKET CAP
12.26M
P/E (TTM)
-1.1076
1D
5D
1M
3M
1Y
5Y
1D
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
TipRanks · 4d ago
Weekly Report: what happened at EDSA last week (1208-1212)?
Weekly Report · 4d ago
Edesa Biotech GAAP EPS of -$1.27 beats by $0.51
Seeking Alpha · 4d ago
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025
TipRanks · 6d ago
Skin drug developer Edesa Biotech's FY net loss widens to $7.2 mln
Reuters · 6d ago
Edesa Biotech Q4 EPS $(0.32) Misses $(0.27) Estimate
Benzinga · 6d ago
EDESA BIOTECH REPORTS FISCAL YEAR 2025 RESULTS
Reuters · 6d ago
Press Release: Edesa Biotech Reports Fiscal Year -2-
Dow Jones · 6d ago
More
About EDSA
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing ways to treat inflammatory and immune-related diseases. The Company’s clinical pipeline is focused on two therapeutic areas: medical dermatology and respiratory. In medical dermatology, the Company is developing EB06, an anti-CXCL10 monoclonal antibody candidate, as a therapy for vitiligo, a common autoimmune disorder that causes skin to lose its color in patches. Its medical dermatology assets also include EB01 (1.0% daniluromer cream), a Phase III-ready asset developed for use as a potential therapy for moderate-to-severe chronic allergic contact dermatitis (ACD), a common occupational skin condition. The Company’s advanced respiratory drug candidate is EB05 (paridiprubart), which is being evaluated in a United States government-funded platform study as a treatment for acute respiratory distress syndrome.

Webull offers Edesa Biotech Inc stock information, including NASDAQ: EDSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDSA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EDSA stock methods without spending real money on the virtual paper trading platform.